PNU-91325 increases fatty acid synthesis from glucose and mitochondrial long chain fatty acid degradation: A comparative tracer-based metabolomics study with rosiglitazone and pioglitazone in HepG2 cells

Metabolomics

Volumn 2, Issue 1, 2006, Pages 21-29

  Harrigan, George G ^a   Colca, Jerry ^a   Szalma, Sándor ^b   Boros, László G ^c  

^a PFIZER INC   (United States)

^b MeTa Informatics   (United States)

^c SIDMAP LLC   (United States)

Author keywords

Diabetes; Fatty acid oxidation; Glucose metabolism; MitoNEET; PNU 91325; Stable isotope based dynamic metabolic profiling (SIDMAP)

Indexed keywords

ANIMALIA;

EID: 33644776521     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-006-0015-5     Document Type: Article

References (26)

1. Boros L.G., Cascante M., Lee W.N. (2002). Metabolic profiling of cell growth and death in cancer: Applications in drug discovery. Drug Discov. Today 7, 364-372
2. Boros L.G., Serkova N.J., Cascante M., Lee W.N. (2004). Use of metabolic pathway flux information in targeted cancer drug design. Drug Discov. Today Therap. Strategies 1, 435-443
3. Colca J.R., McDonald W.G., Waldon D.J., Leone J.W., Lull J.M., Bannow C.A., Lund E.T., Mathews W.R. (2004). Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe. Am. J. Physiol. Endocrinol. Metab. 286, E252-E260
4. Colca, J.R. (2006). Metabolic inflammation and the insulin sensitizers. Biochem. Pharmacol. in press
5. Crosby M.B., Svenson J.L., Zhang J., Nicol C.J., Gonzalez F.J., Gilkeson G.S. (2005). Peroxisome proliferation-activated receptor (PPARγ) is not necessary for synthetic PPARγ agonist inhibitor of inducible nitric-oxide synthase and nitric oxide. J. Pharm. Exp. Therap. 312, 69-76
6. Darmaun D., Matthews D.E., Desjeux J.F., Bier D.M. (1988). Glutamine and glutamate nitrogen exchangeable pools in cultured fibroblasts: A stable isotope study. J. Cell Physiol. 134, 143-148
7. Edvardsson U., Bergstrom M., Alexandersson M., Bamberg K., Ljung B., Dahllof B. (1999). Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice. J. Lipid Res. 40, 1177-1184
8. Guo Y.T., Leng X.S., Li T., Zhao J.M., Lin X.H. (2004). Peroxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats. World J. Gastroenterol. 10, 3419-3423
9. 6] glucose metabolites. Brain Res. 896, 102-117
10. Harrigan G.G., Brackett D.J., Boros L.G. (2005). Medicinal chemistry, metabolic profiling and drug target discovery: A role for metabolic profiling in reverse pharmacology and chemical genetics. Mini. Rev. Med. Chem. 5, 13-20
11. Hellerstein M.K. (1991). Relationship between precursor enrichment and ratio of excess M2/excess M1 isotopomer frequencies in a secreted polymer. J. Biol. Chem. 266, 10920-10924
12. Katz J., Wals P., Lee W.N. (1993). Isotopomer studies of gluconeogenesis and the Krebs cycle with 13C-labeled lactate. J. Biol. Chem. 268, 25509-25521
13. Lee W.N., Byerley L.O., Bergner E.A., Edmond J. (1991). Mass isotopomer analysis: Theoretical and practical considerations. Biol. Mass Spectrom. 20, 451-458
14. Lee W.N., Bergner E.A., Guo Z.K. (1992). Mass isotopomer pattern and precursor-product relationship. Biol. Mass Spectrom 21, 114-122
15. Lee W.N., Edmond J., Bassilian S., Morrow J.W. (1996). Mass isotopomer study of glutamine oxidation and synthesis in primary culture of astrocytes. Dev. Neurosci. 18, 469-477
16. Lee W.N., Lim S., Bassilian S., Bergner E.A., Edmond J. (1998a). Fatty acid cycling in human hepatoma cells and the effects of troglitazone. J. Biol. Chem. 273, 20929-20934
17. 13C2]glucose. Am. J. Physiol. 274, E843-851
18. Leimer K.R., Rice R.H., Gehrke C.W. (1977). Complete mass spectra of N-trifluoroacetyl-n-butyl esters of amino acids. J. Chromatogr. 141, 121-144
19. Lowenstein J.M., Brunengraber H., Wadke M. (1975). Measurement of rates of lipogenesis with deuterated and tritiated water. Methods Enzymol. 35, 279-287
20. Osawa E., Nakajima A., Wada K., Ishimine S., Fujisawa N., Kawamori T., Matsuhashi N., Kadowaki T., Ochiai M., Sekihara H., Nakagama H. (2003). Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 124, 361-367
21. Otto C., Lehrke M., Goke B. (2002). Novel insulin sensitizers: pharmacogenomic aspects. Pharmacogenomics 3, 99-116
22. Sabate L., Franco R., Canela E.I., Centelles J.J., Cascante M. (1995). A model of the pentose phosphate pathway in rat liver cells. Mol. Cell. Biochem. 142, 9-17
23. Tanis S.P., Parker T.T., Colca J.R., Fisher R.M., Kletzein R.F. (1996). Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone. J. Med. Chem. 39, 5053-5063
24. Vance D.E., Vance K.E. (2002). Biochemistry of Lipids, Lipoproteins and Membranes, 4th Ed., Elsevier Science Publishing Co., Inc., New York, pp. 183-187
25. Wilkening S., Stahl F., Bader A. (2003). Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab. Dispos. 31, 1035-1042
26. Wong D.A., Bassilian S., Lim S., Lee W.N. (2004). Coordination of peroxisomal beta-oxidation and fatty acid elongation in HepG2 cells. J. Biol. Chem. 279, 41302-41309